Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
817.00    -5.00 (-0.61%)
Bid:
812.00
Ask:
819.00
Spread: 7.00 (0.862%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

9 May 2017 10:30

RNS Number : 5967E
Savills PLC
09 May 2017
 

9 May 2017

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date Savills has traded in line with our expectations and ahead of the corresponding period in 2016, both as reported and on a constant currency basis.

 

In the UK commercial markets, Savills has maintained a significant share of the Prime Central London investment and leasing markets, although market uncertainty continues to affect transactional volumes. Outside London, our transactional volumes and Professional and Development services have grown over the comparable period in 2016.

 

As expected, volumes in the UK Prime Residential market have been lower in the year to date compared with the very strong comparable period in advance of April 2016's increase in Stamp Duty. Our UK Rural business has performed better than anticipated. The period leading up to the UK General Election is expected to have a short term adverse impact on residential transaction activity over the next few weeks.

 

Savills Asia Pacific business has had a very strong start to the year. We have seen substantial underlying revenue and profit growth in the year to date, with Hong Kong, Australia and Japan all ahead of our expectations; in addition, our reported results continue to benefit from the effect of Sterling weakness.

 

In the US, Savills Studley has had a slower start to the year than initially anticipated with some occupier transaction deferrals. However, the pipeline of activity for the remainder of the year remains good. In addition we have continued to expand our footprint with acquisitions and significant recruitment in Southern California, Denver, Colorado and a Capital Markets team in New York.

 

In Continental Europe, to date we have traded in line with our expectations, with France, the Netherlands, Spain and Italy experiencing a particularly strong start to the year.

 

Globally, our Consultancy and Property Management businesses have delivered continued revenue growth with particular strengths in the UK and Asia.

 

Following a strong year in 2016, Savills Investment Management has grown revenue and profits as anticipated for the period to date as we near the end of the disposal of assets within the liquidating German Open Ended Funds under the SEB brand.

 

While we have started the year well, typically the first four months represent a disproportionately small element of the expected outturn for the full year. Against a political and economic backdrop which demonstrates greater levels of uncertainty than a few months ago, we continue to anticipate that our performance will remain in line with our expectations.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLIFIAELIAIID
Date   Source Headline
11th Nov 20213:19 pmRNSDirector/PDMR Shareholding
11th Nov 20219:16 amRNSDirector/PDMR Shareholding
9th Nov 20217:00 amRNSTrading update
1st Nov 202110:00 amRNSTotal Voting Rights
15th Oct 20212:28 pmRNSHolding(s) in Company
12th Oct 20213:41 pmRNSDirector/PDMR Shareholding
6th Oct 20214:19 pmRNSSIMON HOPE STEPS DOWN FROM SAVILLS EXECUTIVE BOARD
1st Oct 202110:00 amRNSTotal Voting Rights
21st Sep 20211:00 pmRNSDirector/PDMR Shareholding
13th Sep 20211:00 pmRNSDirector/PDMR Shareholding
8th Sep 202110:00 amRNSAdditional Listing
1st Sep 202110:00 amRNSTotal Voting Rights
16th Aug 202111:40 amRNSDirector/PDMR Shareholding
16th Aug 202111:30 amRNSBlock listing Interim Review
11th Aug 20213:27 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSHalf-year Report
2nd Aug 202111:23 amRNSHolding(s) in Company
2nd Aug 202111:23 amRNSTotal Voting Rights
21st Jul 202110:00 amRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
30th Jun 20214:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20212:42 pmRNSDirector/PDMR Shareholding
18th Jun 202111:12 amRNSDirector/PDMR Shareholding
14th Jun 20211:36 pmRNSDirector/PDMR Shareholding
11th Jun 202112:47 pmRNSDirector/PDMR Shareholding
10th Jun 20214:56 pmRNSDirector/PDMR Shareholding
2nd Jun 20212:49 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSTotal Voting Rights
28th May 20211:23 pmRNSCompletion of Acquisition
27th May 20218:04 amRNSSavills IM & Samsung Life Investment Alliance
20th May 202110:45 amRNSOption to acquire outstanding 75% of DRC exercised
12th May 202112:45 pmRNSResult of AGM
12th May 202111:51 amRNSAGM Statement
11th May 202111:00 amRNSDirector/PDMR Shareholding
13th Apr 20211:34 pmRNSDirector/PDMR Shareholding
6th Apr 20213:32 pmRNSAnnual Report and AGM Notice
1st Apr 20213:00 pmRNSTotal Voting Rights
22nd Mar 20219:20 amRNSHolding(s) in Company
11th Mar 20214:45 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSFinal Results
10th Mar 20216:10 pmRNSHolding(s) in Company
1st Mar 202110:07 amRNSTotal Voting Rights
15th Feb 202112:10 pmRNSBlock listing Interim Review
15th Feb 20219:15 amRNSHolding(s) in Company
11th Feb 20214:37 pmRNSHolding(s) in Company
11th Feb 20214:37 pmRNSDirector/PDMR Shareholding
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20219:26 amRNSHolding(s) in Company
21st Jan 20213:37 pmRNSBlock listing Interim Review
18th Jan 20214:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.